/ 9d3b$$de :17:38 jinfa UC: J Infect
|
|
- Lorraine Alexander
- 6 years ago
- Views:
Transcription
1 1629 Presence of Human Immunodeficiency Virus (HIV) Type 1 Subtype A Infection in a New York Community with High HIV Prevalence: A Sentinel Site for Monitoring HIV Genetic Diversity in North America Kathleen L. Irwin, Chou-Pong Pau, Davis Lupo, Danuta Pienazek, Chi-Cheng Luo, Noemi Olivo, Mark Rayfield, Dale J. Hu, J. Todd Weber, Richard A. Respess, Robert Janssen, Patrick Minor, Jerome Ernst, and the Centers for Disease Control and Prevention Bronx Lebanon HIV Serosurvey Team Centers for Disease Control and Prevention, and Orkand Corporation, Atlanta; Bronx Lebanon Hospital Center, Bronx, New York To determine whether US residents are infected with subtypes of human immunodeficiency virus (HIV) type 1 other than subtype B (), the predominant North American subtype with a unique GPGR genetic sequence in the V3 loop, viruses from 22 HIV-infected adults were serotyped and subtyped. Twenty patients had subtype B (), of whom 15 had serotype B (), 3 had serotype A/C, 1 had serotype B (Thai), and 1 had a nontypeable serotype. Two had subtype A, both serotype A/C. Both subtype A infected patients, only 1 of whom had been outside the United States, reported sex with persons traveling abroad, suggesting possible acquisition in the United States. Because US residents are infected with non subtype B () strains, US surveillance for HIV-1 diversity is needed to elucidate subtype-specific transmission patterns and pathogenesis and to guide evaluation and development of HIV diagnostic tests and vaccines. To date, the vast majority of human immunodeficiency virus Materials and Methods type 1 (HIV-1) isolates reported from North America and Europe contain a unique GPGR genetic sequence in the V3 loop During , we studied inpatients and outpatients tip and are classified as group M, subtype B, referred to in this treated at Bronx-Lebanon Hospital Center who met these eligibility report as subtype B () [1]. However, rare cases of criteria: aged years; admitted to medicine, surgery, gynecolinfection with HIV-1 subtypes A, D, and E and group O have ogy, or family practice wards or triaged to the nonurgent emer- been reported in immigrants [2, 3] and in US servicemen who gency department track; not known to be HIV-infected before enrollment; not admitted for AIDS-related conditions; not offered were infected while living overseas [4]. Little is known about HIV testing by nonstudy staff during this admission; physically and the prevalence of non subtype B () subtypes in wellmentally able to complete interviews; and able to speak English or characterized US populations and whether non subtype B Spanish. Eligible patients (n Å 1749) were invited to participate () strains are being transmitted among US residents in voluntary HIV counseling and testing and pre- and posttest who have not traveled abroad. To examine the diversity of interviews about HIV risk behaviors and travel history. Nearly HIV-1 subtypes among US residents, we examined patients half (n Å 828, 47.3%) agreed to testing and interviews. Information with newly identified HIV-1 infection who resided in the South on characteristics of patients who declined interview was not avail- Bronx, New York, a community having one of the highest able from other sources. All HIV-infected participants were newly prevalences of HIV infection and highest proportions of immi- diagnosed. grants and visitors from the Caribbean, Latin America, and Patient sera were tested for HIV antibodies (HIV-1/HIV-2 im- Africa in the United States [5]. munoassay; Genetic Systems, Seattle) and confirmed by blot (Cambridge Biotech, Worcester, MA). The 43 blotpositive specimens were serotyped using investigational EIAs including 10 peptides representing group M subtype V3 loop immunogenic domains of subtypes A, B (), B (Thai), B (Brazilian), C, D, E, and F and group O subtype (Ant-70 and Submitted 27 February 1997; revised 29 May Presented in part: XI International Conference on AIDS, Vancouver, British MVP5180) [6]. Specimens reactive to V3-A or V3-C peptide Columbia, 10 July 1996 (abstract We.C.345). immunoassays were classified as serotype A/C because these im- Financial support: CDC Cooperative Agreement U64/CCU Informed consent was obtained from all patients, and human experimentation munoassays are not highly specific for subtypes A and C [7]. guidelines of the US Department of Health and Human Services and Bronx- Specimens were also serotyped using five peptides derived from Lebanon Hospital Center were followed in the conduct of this research. HIV-1 gp41 transmembrane proteins (groups M and O) and one Reprints or correspondence: Dr. Kathleen Irwin, Division of HIV/AIDS peptide derived from HIV-2 gp36 protein [6]. Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd., Viruses were genetically sequenced from proviral DNA obtained Mail Stop E-45, Atlanta, GA from peripheral blood mononuclear cells [8] or viral RNA ex- The Journal of Infectious Diseases 1997;176: by The University of Chicago. All rights reserved. tracted from serum using QIAamp blood kits (Qiagen, Chatsworth, /97/ $02.00 CA). Samples were amplified using polymerase chain reaction
2 1630 Concise Communications JID 1997;176 (December) (PCR) [9] according to manufacturer s specifications (Perkin Elmer, Foster City, CA). Several primers (Abbott Laboratories, Abbott Park, IL) were used to generate a 525-nucleotide fragment of the C2-V3 envelope region: for primary PCR, JH44F (5 -ACA- GTRCARTGYACACATGG, nt ) and JH35mR (5 - CACTTCTCCAATTGTCCITCA, nt ); for nested PCR, JH33F (5 -CTGTTIAATGGCAGICTAGC, nt ) and JH48R (5 -RATGGGAGGRGYATACAT, nt ). When required, viral RNA was reverse-transcribed using primer JH35mR. Nucleotide positions were based on HIV MN complete genome Genbank accession number M All PCR products were purified (QIAquick purification kits; Qiagen) and were subjected to automated sequence analysis using dye terminator cyclesequencing reagents and protocols (ABI PRISM; Perkin Elmer). Phylogenetic analysis was performed using neighbor-joining methods with bootstrap resampling [10]. denied foreign birthplace or travel but reported having had sex with partners who had spent time in the Caribbean, Latin America, or Africa. Patient BX912 was born in Africa but declined to provide information on the age at which he moved to the United States or the country in which sexual activities with persons who had spent time in the Caribbean, Latin America, or Africa had taken place. Both patients infected with subtype A (BX866 and BX912) reported having recently practiced unprotected heterosexual sex. Both denied having received transfusions before The demographic and HIV risk characteristics of the 2 patients with subtype A infection and the patients with confirmed subtype B () infection were not statistically different at P õ.05 using Fisher s exact test (data not shown). Discussion Results Of the 43 newly identified HIV-infected hospital patients, 2 Of the 828 patients tested for HIV-1, 43 (5.2%) were seropositive; (4.7%) were infected with HIV-1 subtype A. We may have failed none of the 43 had serotype or genotype consistent to detect other non subtype B () strains in this commu- with HIV-1 group 0 or HIV-2 infection. Thirty-five (81.4%) nity because we enrolled only English and Spanish speakers and of 43 patients had serotype B (). C2-V3 envelope re- because patients, including Africans, who spoke only French or gions were sequenced from 15 of these 35 patients, of whom African languages, were ineligible. However, õ20 patients ap- 6 were foreign-born and 9 were US-born patients who denied proached for the study were ineligible for this reason. travel outside the continental United States and sex with persons To our knowledge, this is the first report of subtype A infection who had spent time in the Caribbean, Latin America, or in an American-born US resident who had not traveled outside the Africa. All 15 had subtype B () (figure 1). Eight of the United States. The epidemiologic characteristics of the 2 patients 43 (18.6%) patients had non B () serotypes: 6 infected with subtype A indicate that they may have acquired (BX866, BX912, BX269, BX536, BX658, and BX134) had their infections while residing in the United States, although non serotype A/C, 1 (BX130) had serotype B (Thai), and 1 (BX500) locally acquired infection cannot be ruled out for the patient born was classified as nontypeable because the patient s serum reacted in Africa. Three patients with serotype A/C infected with subtype strongly to the gp41-lai peptide characteristic of HIV- B () strains had V3 loop sequences that were atypical of 1 group M but lacked reactivity to all V3 peptides (table 1). the subtype B () strains most commonly recovered in the C2-V3 envelope regions were sequenced from 7 of these 8 United States and thus reacted more strongly to the serotype A patients, for whom we had adequate specimen volume. Two immunoassays than to the serotype B () immunoassays. patients classified as serotype A/C were infected with viruses As others have reported [11 14], this may be due to infection of subtype A sequences (BX866 and BX912), and 5 patients with 2 virus strains (A and B []), a recombinant strain, were infected with HIV subtype B () (figure 1). The or a subtype B () strain with a V3 loop sequence that immunogenic domain of the V3 region of the virus infecting differed substantially from other US strains that have been se- patient BX130 (GPGQAWY) was more similar to B (Thai) quenced. However, additional sequencing would be needed to strains (GPGQAWY) than to other sequenced subtype B strains confirm any of these explanations. Patient BX500, who had sub- (GPGRAFY) and thus was classified as serotype B (Thai). type B () virus but was nonreactive to all 10 V3 loop However, more extensive phylogenetic analysis of the C2-V3 peptides, may have lacked measurable antibody to the V3 loop, envelope region sequence revealed only a weak association a finding reported in seroconverters infected with subtype B (characterized by very low, unstable bootstrap values) with () viruses [15, 16]. This and other studies [16] demonstrate sequences from 16 B (Thai) strains (data not shown). This that serotype based on these V3 loop and gp41 peptides and analysis, therefore, suggested that the patient s virus was most subtyping by sequencing analysis does not always agree. How- consistent with subtype B () (figure 1). Patient BX500, ever, serotyping was useful to distinguish patients with subtype who lacked reactivity to all V3 loop peptides, had an unusual B () viruses with typical sequences from patients with GPGKV motif within the V3 loop sequence instead of the non B () viruses or B () viruses with unusual GPGRA motif typical of subtype B () strains. sequences. The 7 patients with non B () serotypes whose vi- Our report and others [2 4] of US residents infected with ruses underwent genotyping had diverse characteristics (table non subtype B () viruses indicate that multiple intro- 1). Of note, patient BX866, who was infected with subtype A, ductions of HIV-1 have occurred in North America and will
3 JID 1997;176 (December) Concise Communications 1631 Figure 1. Phylogenetic classification of HIV-1 strains of 22 patients from Bronx, New York. Nos. to left side of branch nodes indicate probabilities based on bootstrap resampling evaluations of 100 data sets. Nos. to right of branch nodes indicate patient identification numbers; Bronx patients are denoted with BX prefix. Patients infected with subtype A viruses are marked with arrowheads. Classification of distant HIV-1 subtypes A H are delineated by uppercase letters on right. Sequence information has been deposited in GenBank (accession nos. U90181 U90202).
4 1632 Concise Communications JID 1997;176 (December) Table 1. Selected characteristics of patients with newly identified HIV-1 infection with non subtype B () serotype, Bronx, New York, High-risk Patient Years in Travel outside Sex partner with heterosexual Male-to- Ever no. Serotype Genotype Sex Birthplace Bronx 50 US states foreign travel* behaviors male sex injected BX866 A/C A F New York City 10 No Yes Yes NA No BX912 A/C A M Gambia?? Yes? No No BX269 A/C B F New York City 8 No No Yes NA Yes BX536 A/C B M Continental US 10 No Yes Yes No Yes BX658 A/C B M Puerto Rico 10 Puerto Rico Yes No Yes No BX134 A/C Not done M Mali 2 Burundi, Yes Yes No No Canada BX130 B Thai B M Puerto Rico 10 Puerto Rico No Yes No No BX500 Nontypeable B M New York City?? Yes? Yes No NOTE. M, male; F, female; NA, not applicable, female patient;?, unknown; US, United States. * Defined as partner who was born in or spent time in Caribbean, Latin America, or Africa. Defined as having engaged in commercial sex work or sexual contact with commercial sex worker, an HIV-infected person, drug injector, or transfusion recipient, or for women, bisexual man. We are indebted for the invaluable contributions of study team members not listed as authors: Stephen Bekoe-Tabiri, Franklin Benjamin, Stere Carniciu, Carlos Chavaria, Vicsa Chiriboga, Maura Disla, Auria Fernandez, Camelia Ganea, Gilbert Martinez, Reineisse Parsons, Felipe Rosario, William Rothman, Wanda San- tos, Rita Shulman, and Yvette Vasquez, from Bronx-Lebanon Hospital Center; and Karen Brown, Faye Cowart, Avis Daugharty, Marty Edeline, Ernest Lewis, Brent McRae, Vincent Raimondi, Charles Schable, Gerald Schochetman, Larry Wells, and Roy Win- ter, from the Centers for Disease Control and Prevention. probably continue to occur. The strain diversity in our study population may be due to either recent introduction of new strains from outside the United States or to local transmission of non subtype B () strains established in the community. Because the 2 patients with non subtype B () strains had recently practiced unprotected sex, local transmission of these variants may be ongoing. Surveillance that links genetic, epidemiologic, and clinical characteristics in sentinel North American communities with high HIV incidence such as the Bronx may be useful to elucidate subtype-specific patterns of HIV-1 transmission and pathogenesis and to determine if the genetic diversity of HIV-1 will alter the dynamics of the epidemic in North America. Because serotype and subtype are not always consistent and serotyping is less complex and costly than genetic subtyping with genetic sequencing, serotyping is best used to screen large numbers of specimens for peptide reactivity that is inconsistent with subtype B () strains. Specimens with such atypical reactivity should then be genetically sequenced to confirm subtype. In our study, no demographic or HIV risk characteristic that might be useful for identifying patients who might benefit from genetic subtyping (e.g., the interpretation of some HIV virus load assays may depend on subtype [17]) was signifi- cantly associated with the presence of non subtype B () infection. However, the very small sample size limited the statistical power of this analysis. There is no evidence that the HIV-1 infections characterized by either non B () serotype or non B () subtype identified in this study would have compromised blood safety because all 8 patients tested positive on commercial HIV tests and presumably would have tested positive if they had donated blood. Because all 8 denied having received transfusions before 1985, when US blood banks began screening blood for HIV, transfusion-related acquisition is unlikely. The presence of non subtype B () viruses among US residents may also have important implications for HIV diagnostic test sensitivity, ensuring blood safety, and vaccine development. Most HIV tests used to diagnose infection or screen blood in North America are based primarily on subtype B () strains, and their sensitivity for detecting non subtype B () strains requires further evaluation [1]. If ongoing surveillance indicates a high prevalence of non subtype B () strains in US communities that could benefit greatly from HIV vaccines, the development of polyvalent vaccines for use in North America will be warranted. Acknowledgments References 1. Hu DJ, Dondero TJ, Rayfield MA, et al. The emerging genetic diversity of HIV. JAMA 1996;275:210 6.
5 JID 1997;176 (December) Concise Communications Gao F, Yue L, Hill SC, et al. HIV-1 sequence subtype D in the United 11. Artenstein AW, VanCott TC, Mascola JR, et al. Dual infection with human States. AIDS Res Hum Retroviruses 1994;10: immunodeficiency virus type 1 of distinct envelope subtypes in humans. 3. Centers for Disease Control and Prevention. Identification of HIV-1 group O J Infect Dis 1995;171: infection Los Angeles County, California, MMWR 1996;45: Pieniazek D, Janini LM, Ramos A, et al. HIV-1 patients may harbour 4. Brodine SK, Mascola JR, Weiss PJ, et al. Detection of diverse HIV-1 viruses of different phylogenetic subtypes: implications for the evolution genetic subtypes in the USA. Lancet 1995;356:1198. of the HIV/AIDS pandemic. Emerg Infect Dis 1995;1: Irwin KL, Olivo N, Schable C, et al. Absence of HIV-2 infection in a 13. Robertson DL, Sharp PM, McCutchan FE, Hahn BH. Recombination of U.S. population at high risk. Transfusion 1996;36: HIV-1. Nature 1995;374: Pau CP, Hu DJ, Spruill C, et al. Surveillance for human immunodeficiency 14. Xin KQ, Shapshak P, Kawamoto S, et al. Highly divergent env sequences of virus type 1 group O infections in the United States. Transfusion 1996; HIV-1 B subtype with two novel V3 loop motifs detected in an AIDS patient 36: in Miami, Florida. AIDS Res Hum Retroviruses 1995;11: Cheingsong-Popov R, Lister S, Callow D, et al. Serotyping HIV Type Holmback K, Kusk P, Hulgaard EF, Bugge TH, Scheibel E, Lindhardt by antibody binding to the V3 loop: relationship to viral genotype. BO. Autologous antibody response against the principal neutralizing AIDS Res Hum Retroviruses 1994;10: domain of human immunodeficiency virus type 1 isolated from infected 8. Velleca WM, Palmer DF, Feorino P et al. Isolation, culture, and identifica- humans. J Virol 1993;67: tion of human immunodeficiency virus. Atlanta: Centers for Disease 16. Pau CP, Kai M, Holloman-Candal DL, et al. Antigenic variation and serotyp- Control and Prevention, ing of HIV type 1 from four World Health Organization sponsored HIV 9. Wang AM, Doyle MV, Mark DF. Quantitation of mrna by the polymerase vaccine sites. AIDS Res Hum Retroviruses 1994;10: chain reaction. Proc Natl Acad Sci USA 1989;86: Dunne AL, Crowe SM. Comparison of branched DNA and reverse tran- 10. Felsenstein J. PHYLIP, Phylogeny Inference Package, version 3.5. Cladistics scriptase polymerase chain reaction for quantifying six different HIV- 1989;5: subtypes in plasma. AIDS 1997;11: Cytokine Profiles in Cerebrospinal Fluid of Human Immunodeficiency Virus Infected Patients with Cryptococcal Meningitis: No Leukocytosis despite High Interleukin-8 Levels Wendy Chaka, Robert Heyderman, Innocent Gangaidzo, Valerie Robertson, Peter Mason, University of Zimbabwe Meningitis Group, Jan Verhoef, André Verheul, and Andy I. M. Hoepelman Eijkman-Winkler Institute for Microbiology, Infectious Diseases and Inflammation, and Department of Internal Medicine, Division of Infectious Diseases and AIDS, University Hospital Utrecht, Utrecht, The Netherlands; University of Zimbabwe Medical School, Harare, Zimbabwe Cytokine levels were studied in the cerebrospinal fluid (CSF) of 16 adults with cryptococcal meningitis (CM). Low levels of tumor necrosis factor (TNF)-a and interferon-g, high levels of interleukin (IL)-1b, IL-6, and IL-8, and the presence of IL-10 were documented. There were no significant differences in levels of TNF-a and interferon-g for CM and control patients. Mean CSF levels of IL-1b (139.5 pg/ml), IL-6 (346 pg/ml), IL-8 (1160 pg/ml), and IL-10 (9.27 pg/ml) were significantly (P õ.01) elevated in CM patients compared with levels in control patients. Despite the high CSF levels of IL-8, minimal leukocytosis was seen. Significant correlations between cryptococcal antigen titers and IL-10 levels (r Å.8, P õ.05), protein and cryptococcal antigen titer (r Å.9, P õ.05), and protein and IL-10 levels (r Å.8, P õ.05) were found. Cryptococcosis, the disease caused by the yeast-like fungus fected patients [1 3]. Meningitis is the most frequent complication of cryptococcosis. The clinical presentation of this disease, Cryptococcus neoformans, is a major cause of morbidity and mortality in patients with compromised cell-mediated immuated with nonspecific symptoms, such as headache and fever which is often fatal, may be insidious and is commonly associ- nity, particularly human immunodeficiency virus (HIV) in- [1, 2]. In sub-saharan Africa, C. neoformans has become the most frequent cause of adult meningitis in the last decade [3] (Heyderman R, et al., unpublished data). Received 3 February 1997; revised 27 May It has been suggested that different cytokine profiles are Ethical approval of this study was given by the Medical Research Council of Zimbabwe. reflected in differences in the clinical presentations of bacterial, Reprints or correspondence: Dr. I. M. Hoepelman, University Hospital viral, or tuberculous meningitis. Acute bacterial meningitis, Utrecht, Dept. of Internal Medicine, Division of Infectious Diseases and AIDS, with its clinical picture of abrupt onset, severe illness, and high P.O. Box 85500, 3508 GA Utrecht, The Netherlands. mortality, is characterized by a sharp increase in the proin- The Journal of Infectious Diseases 1997;176: flammatory cytokines tumor necrosis factor (TNF)-a, interleu by The University of Chicago. All rights reserved /97/ $02.00 kin (IL)-1b, IL-6, and IL-8 [4]. In contrast, the clinically milder
Materials and Methods
470 Presence of Human Immunodeficiency Virus (HIV) Type 1, Group M, Non-B Subtypes, Bronx, New York: A Sentinel Site for Monitoring HIV Genetic Diversity in the United States Paul J. Weidle, 1,3 Camelia
More informationHEPATITIS C, ACUTE CRUDE DATA. Number of Cases 5 Annual Incidence a LA County 0.05 California b 0.10 United States b 0.68 Age at Diagnosis Mean 38
2016 Annual Morbidity Report HEPATITIS C, ACUTE a Rates calculated based on less than 19 cases or events are considered unreliable b Calculated from: CDC. Notice to Readers: Final 2016 Reports of Nationally
More informationTwo Percent of HIV-Positive U.S. Blood Donors Are Infected with Non-subtype B Strains ABSTRACT
AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 19, Number 12, 2003, pp. 1065 1070 Mary Ann Liebert, Inc. Two Percent of HIV-Positive U.S. Blood Donors Are Infected with Non-subtype B Strains ERIC L. DELWART,
More informationYale University, New Haven, CT, USA
HEPATITIS C VIRUS INFECTION IS UBIQUITOUS AMONG DRUG INJECTORS IN ST. PETERSBURG, RF Robert Heimer 1, Elijah Paintsil 1, Sergei Verevochkin 2, Russell Barbour 1, Edward d White 1, Olga Toussova 2, Linda
More informationEDMA HIV-AIDS TEAM Fact Sheet November 2007
EDMA HIV-AIDS TEAM Fact Sheet November 2007 1. HIV Facts AIDS epidemic update UNAIDS Epidemic Update, November 2007 (1) 760,000 people to be living with HIV in Western and Central Europe in 2007. 31,000
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending February
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending March
More informationChronic HIV-1 Infection Frequently Fails to Protect against Superinfection
Chronic HIV-1 Infection Frequently Fails to Protect against Superinfection Anne Piantadosi 1,2[, Bhavna Chohan 1,2[, Vrasha Chohan 3, R. Scott McClelland 3,4,5, Julie Overbaugh 1,2* 1 Division of Human
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending April
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending February
More informationWeekly Influenza & Respiratory Illness Activity Report
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending February
More informationTexas Influenza Summary Report, Season (September 28, 2008 April 11, 2009)
Texas Influenza Summary Report, 2008 2009 Season (September 28, 2008 April 11, 2009) Background Influenza and influenza-like illnesses (ILI) were last reportable by law in any county in Texas in 1993 (1).
More informationComplicated viral infections
Complicated viral infections Clinical case discussion Diagnostic dilemmas NSW State Reference Laboratory for HIV St Vincent s Hospital Sydney Diagnostic dilemmas Indeterminate or discordant serology (western
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending January
More informationNew HIV Tests and Algorithm: A change we can believe in
New HIV Tests and Algorithm: A change we can believe in Esther Babady, PhD, D (ABMM) Memorial Sloan-Kettering Cancer Center New York, New York Learning Objectives After this presentation you should be
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending March
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending October
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending December
More informationHIV-1 Dual Infection and Neurocognitive Impairment
HIV-1 Dual Infection and Neurocognitive Impairment Gabriel Wagner, MD Assistant Professor of Medicine Infectious Diseases & Global Public Health UC San Diego HIV-Associated End Organ Damage Antiretroviral
More informationHIV Lecture. Anucha Apisarnthanarak, MD Division of Infectious Diseases Thammasart University Hospital
HIV Lecture Anucha Apisarnthanarak, MD Division of Infectious Diseases Thammasart University Hospital End-2001 global estimates for children and adults People living with HIV/AIDS New HIV infections in
More informationEpidemiological profiles of viral hepatitis in Italy Effects of migration
Epidemiological profiles of viral hepatitis in Italy Effects of migration Hepatitis A and E T. Santantonio UOC di Malattie Infettive Università degli Studi di Foggia Azienda Ospedaliero-Universitaria Ospedali
More informationSexually Transmitted Infection Treatment and HIV Prevention
Sexually Transmitted Infection Treatment and HIV Prevention Toye Brewer, MD Co-Director, Fogarty International Training Program University of Miami Miller School of Medicine STI Treatment and HIV Prevention.
More informationMonitoring Recent HIV Infection in Ireland, 2017
Monitoring Recent HIV Infection in Ireland, 2017 January 2019 Key Facts 1 13% of HIV diagnoses in 2017 (of those tested) were likely to be recent infections (within 4 months), using the Recent Infection
More informationAn Evolutionary Story about HIV
An Evolutionary Story about HIV Charles Goodnight University of Vermont Based on Freeman and Herron Evolutionary Analysis The Aids Epidemic HIV has infected 60 million people. 1/3 have died so far Worst
More informationWeekly Influenza & Respiratory Illness Activity Report
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending March
More informationRESEARCH ON AIDS IN LATIN AMERICA AND THE CARIBBEAN
ACHR 29/93.10 Original: Spanish RESEARCH ON AIDS IN LATIN AMERICA AND THE CARIBBEAN Division of Communicable Diseases Prevention and Control Program of AIDS and Sexually Transmitted Diseases July 1993.1..
More information5. Over the last ten years, the proportion of HIV-infected persons who are women has: a. Increased b. Decreased c. Remained about the same 1
Epidemiology 227 April 24, 2009 MID-TERM EXAMINATION Select the best answer for the multiple choice questions. There are 60 questions and 9 pages on the examination. Each question will count one point.
More informationMID-TERM EXAMINATION
Epidemiology 227 May 2, 2007 MID-TERM EXAMINATION Select the best answer for the multiple choice questions. There are 75 questions and 11 pages on the examination. Each question will count one point. Notify
More informationVIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...
8 April 2014 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH PROGRAMME SUBCOMMITTEE Sixty-fourth session Brazzaville, Republic of Congo, 9 11 June 2014 Provisional agenda item 6 VIRAL HEPATITIS: SITUATION
More informationHIV Testing. ECHO Hep C. Judith Feinberg, MD June 22, 2017
HIV Testing ECHO Hep C Judith Feinberg, MD June 22, 2017 Overview A few basics HIV epidemiology in the US HIV testing Time course of HIV-1 infection symptoms HIV proviral DNA symptoms window period HIV
More informationVIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...
5 November 2014 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-fourth session Cotonou, Republic of Benin, 3 7 November 2014 Provisional agenda item 11 VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES
More informationHIV 101: Fundamentals of HIV Infection
HIV 101: Fundamentals of HIV Infection David H. Spach, MD Professor of Medicine University of Washington Seattle, Washington Learning Objectives After attending this presentation, learners will be able
More informationHIV Update in Laboratory Testing. Patricia Slev, PhD, D(ABCC)
HIV Update in Laboratory Testing Patricia Slev, PhD, D(ABCC) Objectives Explain the advances in HIV diagnostics, including fourth generation Ag/Ab combination HIV screening assays Describe the new CDC
More informationA demographic and health pro le of gay and bisexual men in a large Canadian urban setting
AIDS CARE (2002), VOL. 14, NO. 1, pp. 111 115 A demographic and health pro le of gay and bisexual men in a large Canadian urban setting S. LOW-BEER, 1 K. BARTHOLOMEW, 2 A. E. WEBER, 1 K. CHAN, 1 M. LANDOLT,
More informationMicropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ
www.micropathology.com info@micropathology.com Micropathology Ltd Tel 24hrs: +44 (0) 24-76 323222 Fax / Ans: +44 (0) 24-76 - 323333 University of Warwick Science Park, Venture Centre, Sir William Lyons
More informationCONCISE COMMUNICATION
1791 CONCISE COMMUNICATION Detection of Diverse Variants of Human Immunodeficiency Virus 1 Groups M, N, and O and Simian Immunodeficiency Viruses from Chimpanzees by Using Generic pol and env Primer Pairs
More informationTHE BASICS. WHAT IS THE RED RIBBON? The Red Ribbon is the international symbol of HIV and AIDS awareness. It stands for:
THE BASICS WHAT IS THE RED RIBBON? The Red Ribbon is the international symbol of HIV and AIDS awareness. It stands for: CARE AND CONCERN It is being worn by increasing numbers of people around the world
More informationHealthcare-Related Outbreaks of Hepatitis B and C in the United States
Healthcare-Related Outbreaks of Hepatitis B and C in the United States Ian T. Williams, PhD, MS Epidemiology Branch Division of Viral Hepatitis National Center for Infectious Diseases Centers for Disease
More informationPertussis: An Emerging Infection. Holly K. Ehrke. Ferris State University
Running head: PERTUSSIS AN EMERGING INFECTION 1 Pertussis: An Emerging Infection Holly K. Ehrke Ferris State University PERTUSSIS AN EMERGING INFECTION 2 Abstract Pertussis is a highly contagious disease
More informationHIV/AIDS & Immune Evasion Strategies. The Year First Encounter: Dr. Michael Gottleib. Micro 320: Infectious Disease & Defense
Micro 320: Infectious Disease & Defense HIV/AIDS & Immune Evasion Strategies Wilmore Webley Dept. of Microbiology The Year 1981 Reported by MS Gottlieb, MD, HM Schanker, MD, PT Fan, MD, A Saxon, MD, JD
More informationAn Analysis of Genital Tract Derived HIV from Heterosexual Transmission Pairs. Debrah Boeras Emory University October 14, 2008
An Analysis of Genital Tract Derived HIV from Heterosexual Transmission Pairs Debrah Boeras Emory University October 14, 2008 Background A majority of HIV-1 infections occur through heterosexual exposure
More informationSurveillance of influenza in Northern Ireland
Surveillance of influenza in Northern Ireland 2011-2012 Summary: The influenza season started later than normal, clinical indices began to increase marginally in mid-february, much later than previous
More informationLEARNING FROM OUTBREAKS: SARS
LEARNING FROM OUTBREAKS: SARS IFIC - APECIH 2017 KATHRYN N. SUH, MD, FRCPC 29 SEPTEMBER 2017 www.ottawahospital.on.ca Affiliated with Affilié à SEVERE ACUTE RESPIRATORY SYNDROME (SARS) Nov 2002 southern
More informationGuidance for Industry
Guidance for Industry Lookback for Hepatitis C Virus (HCV): Product Quarantine, Consignee Notification, Further Testing, Product Disposition, and Notification of Transfusion Recipients Based on Donor Test
More informationWhat s Lurking out there??????
What s Lurking out there?????? Dave Warshauer, PhD, D(ABMM) Deputy Director, Communicable Diseases Wisconsin State Laboratory of Hygiene david.warshauer@slh.wisc.edu WISCONSIN STATE LABORATORY OF HYGIENE
More informationHIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital
HIV-1 Subtypes: An Overview Anna Maria Geretti Royal Free Hospital Group M Subtypes A (1, 2, 3) B C D F (1, 2) G H J K Mechanisms of HIV-1 genetic diversification Point mutations RT error rate: ~1 per
More information10/6/2014. INFLUENZA: Why Should We Take The Vaccine? OUTLINE INFLUNZA VIRUS INFLUENZA VIRUS INFLUENZA VIRUS
INFLUENZA: Why Should We Take The Vaccine? Baptist Hospital Baptist Children s Hospital Doctors Hospital J. Milton Gaviria, MD, FACP October 17, 2014 Homestead Hospital Mariners Hospital Baptist Cardiac
More informationARCHITECT HIV Ag/Ab Combo: Moving HIV Diagnostics Forward in the U.S.
ARCHITECT HIV Ag/Ab Combo: Moving HIV Diagnostics Forward in the U.S. Catherine Brennan, Ph.D. Research Fellow Infectious Diseases Research Abbott Diagnostics 1 Agenda ARCHITECT HIV Ag/Ab Combo Assay What
More informationImmunodeficiencies HIV/AIDS
Immunodeficiencies HIV/AIDS Immunodeficiencies Due to impaired function of one or more components of the immune or inflammatory responses. Problem may be with: B cells T cells phagocytes or complement
More informationEvolution of influenza
Evolution of influenza Today: 1. Global health impact of flu - why should we care? 2. - what are the components of the virus and how do they change? 3. Where does influenza come from? - are there animal
More informationHepatitis C Best Practice Guidelines For Local Health Departments
Hepatitis C Best Practice Guidelines For Local Health Departments LHDs are responsible for investigating and reporting all physician reported cases of acute hepatitis C (HCV). For clients known to have
More information(ii) The effective population size may be lower than expected due to variability between individuals in infectiousness.
Supplementary methods Details of timepoints Caió sequences were derived from: HIV-2 gag (n = 86) 16 sequences from 1996, 10 from 2003, 45 from 2006, 13 from 2007 and two from 2008. HIV-2 env (n = 70) 21
More informationPHSKC HIV Testing Survey: Knowledge, Attitudes and Practices
PHSKC HIV Testing Survey: Knowledge, Attitudes and Practices Page One This anonymous survey is intended to collect information about HIV testing attitudes and practices. Results will be used by Public
More informationBuve, A., H. A. Weiss, et al. (2001). The epidemiology of trichomoniasis in women in four African cities. Aids 15 Suppl 4: S89-96.
Behets, F., J. Andriamiadana, et al. (2001). Sexually transmitted infections and associated socio-demographic and behavioural factors in women seeking primary care suggest Madagascar's vulnerability to
More informationHIV Testing Survey, 2002
Special Surveillance Report Number 5 HIV Testing Survey, 2002 DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Centers for Disease Control and Prevention Atlanta, Georgia 30333 . The HIV/AIDS
More informationAIDS in Colombia. Health with up-to-date information on the prevalence of HIV infection in the country.
AIDS in Colombia JORGE BOSHELL S.,l MANUEL G. GACHARNA,~ MARCELA GARcfA,3 Luz SOCORRO JARAMILLO,~ GLADYS ~RQUEZ,~ MARIA MERCEDES FERGUSSON,~ STELLA GONZALEZ,~ ELSA Y. PRADA,~ ROSANA DE RANGEL,~ & ROSALBA
More informationThe Global State of HIV/AIDS. Presented By: Siobhan K. Young, MPH PhD Candidate at UNC Chapel Hill
The Global State of HIV/AIDS Presented By: Siobhan K. Young, MPH PhD Candidate at UNC Chapel Hill siobhany@email.unc.edu Outline HIV/AIDS 101 Origin of AIDS State of the Epidemic HIV/AIDS in Sub-Saharan
More informationState of California Health and Human Services Agency Department of Health Services
State of California Health and Human Services Agency Department of Health Services SANDRA SHEWRY Director ARNOLD SCHWARZENEGGER Governor TO: INTERESTED PARTIES SUBJECT: CALIFORNIA HIV SEROPREVALENCE ANNUAL
More informationNew tools for diagnosis and surveillance
New tools for diagnosis and surveillance Beth A Skaggs, PhD Laboratory Advisor, Division of Global HIV/AIDS CDC-Mozambique AIDS MEDICINES AND DIAGNOSTICS (AMDS) ANNUAL STAKEHOLDERS AND PARTNERS MEETING
More informationCommunicable Disease. Introduction
Communicable Disease HIGHLIGHTS Seniors have the highest incidence rates of tuberculosis compared to other age groups. The incidence rates for TB have been higher among Peel seniors compared to Ontario
More informationLearning Objectives. New HIV Testing Algorithm from CDC. Overview of HIV infection and disease 3/15/2016
New HIV Testing Algorithm from CDC ASCLS-Michigan March 31, 2016 Dr. Kathleen Hoag Learning Objectives Following attendance and review of material provided, attendees will be able to: 1. Describe the new
More informationThe Alphabet Soup of Viral Hepatitis Testing
The Alphabet Soup of Viral Hepatitis Testing August 18, 2011 Patricia Slev, PhD, DABCC Medical Director, Serologic Hepatitis and Retrovirus Laboratory, ARUP Laboratories Assistant Professor of Pathology,
More informationSurveillance for encephalitis in Bangladesh: preliminary results
Surveillance for encephalitis in Bangladesh: preliminary results In Asia, the epidemiology and aetiology of encephalitis remain largely unknown, particularly in Bangladesh. A prospective, hospital-based
More informationINTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE
Ankamma A,, 2014; Volume 3(5): 510-515 INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE STUDY OF SEROPREVALENCE OF HSV-2 AMONG HIV SEROPOSITIVE INDIVIDUALS AT S.V.R.R.G.G.H TIRUPATI ANKAMMA
More informationCopyright, 1995, by the Massachusetts Medical Society
Copyright, 1995, by the Massachusetts Medical Society Volume 333 DECEMBER 28, 1995 Number 26 ESTIMATED RISK OF TRANSMISSION OF THE HUMAN IMMUNODEFICIENCY VIRUS BY SCREENED BLOOD IN THE UNITED STATES EVE
More information-HCV genome is about 9400 nucleotides long, it is ssrna and positive sense -the 10 viral proteins are first made as a large polyprotein -individual
2013: HCV Genome -HCV genome is about 9400 nucleotides long, it is ssrna and positive sense -the 10 viral proteins are first made as a large polyprotein -individual proteins are released from polyprotein
More informationSequence Note. The Molecular Epidemiology and Drug Resistance Determination of HIV Type 1 Subtype B Infection in Barbados ABSTRACT
AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 19, Number 4, 2003, pp. 313 319 Mary Ann Liebert, Inc. Sequence Note The Molecular Epidemiology and Drug Resistance Determination of HIV Type 1 Subtype B Infection
More informationMonitoring For Rotavirus Serotypes In The Americas. Jon Gentsch
Monitoring For Rotavirus Serotypes In The Americas Jon Gentsch Centers for Disease Control and Prevention, Atlanta, USA * The findings and conclusions in this presentation are those of the authors and
More informationZika: Deet, There It Is. Anna Powell, MD Reproductive Infectious Disease Fellow THEGOS
Zika: Deet, There It Is Anna Powell, MD Reproductive Infectious Disease Fellow THEGOS Disclosure I have no financial disclosures or conflicts of interest Lessons from Rubella At peak of rubella epidemic
More informationZika Virus Update for Emergency Care Providers
Zika Virus Update for Emergency Care Providers What is this Zika Virus? Jeff Doerr Epidemiologist Southeastern Idaho Public Health Zika Virus Single stranded RNA virus Genus Flavivirus, Family Flaviviridae
More informationLecture 2: Virology. I. Background
Lecture 2: Virology I. Background A. Properties 1. Simple biological systems a. Aggregates of nucleic acids and protein 2. Non-living a. Cannot reproduce or carry out metabolic activities outside of a
More informationThe case for HIV screening
Briefing Paper 5.2 www.migrationwatchuk.org The case for HIV screening Summary - Since 1997, heterosexual intercourse has become the largest and fastest growing exposure category for human immunodeficiency
More informationSurveillance of Recent HIV Infections: Using a Pointof-Care Recency Test to Rapidly Detect and Respond to Recent Infections
Surveillance of Recent HIV Infections: Using a Pointof-Care Recency Test to Rapidly Detect and Respond to Recent Infections WHAT WAS THE PROBLEM? As countries make progress towards universal coverage of
More informationObjectives. HIV in the Trenches HIV Update for the Primary Care Provider, An Overview The HIV Continuum of Care.
1:30 2:30pm HIV Update SPEAKER Gordon Dickinson, MD Presenter Disclosure Information The following relationships exist related to this presentation: Gordon Dickinson, MD, has no financial relationships
More informationGuidance for Investigation and Management of Zika Virus Infection
Guidance for Investigation and Management of Zika Virus Infection Update: February 11, 2016 Public Health Agency of Canada has issued recommendations from the Committee to Advise on Tropical Medicine and
More informationMosquitoborne Viral Diseases
Mosquitoborne Viral Diseases Originally prepared by Tom J. Sidwa, D.V.M, M.P.H State Public Health Veterinarian Zoonosis Control Branch Manager Texas Department of State Health Services 1 AGENT Viruses
More informationDr. Charles Tobin-West Department of Preventive and Social Medicine College of Health Sciences University of Port Harcourt
Dr. Charles Tobin-West Department of Preventive and Social Medicine College of Health Sciences University of Port Harcourt Sexual risk behaviors are among the key drivers of the HIV epidemic in Nigeria,
More informationARIZONA INFLUENZA SUMMARY Week 1 (1/4/2015 1/10/2015)
ARIZONA INFLUENZA SUMMARY Week 1 (1/4/2015 1/10/2015) 2014-2015 Season (9/28/2014 10/3/2015) Synopsis: Influenza activity is increasing in Arizona. Arizona reported Widespread activity for week 1. Influenza
More informationHIV and PEP. LTC Rose Ressner WRNMMC ID staff Oct 2014 UNCLASSIFIED
HIV and PEP LTC Rose Ressner WRNMMC ID staff Oct 2014 UNCLASSIFIED Disclaimer The views expressed in this presentation are those of the speaker and do not reflect the official policy of the Department
More information: AccuPower ZIKV(DENV, CHIKV) Multiplex Real-Time RT-PCR Kit. Copyright, Bioneer Corporation. All rights reserved.
: AccuPower ZIKV(DENV, CHIKV) Multiplex Real-Time RT-PCR Kit Copyright, Bioneer Corporation. All rights reserved. 1. Offers superior diagnostic accuracy compared to immunoassay Allows precision diagnosis,
More informationUse of molecular surveillance data to identify clusters of recent and rapid HIV transmission
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Use of molecular surveillance data to identify clusters of recent and rapid HIV transmission Alexa Oster, MD Acting Lead, Incidence
More informationReceptive Anal Intercourse and HIV Infection
World Journal of AIDS, 2017, 7, 269-278 http://www.scirp.org/journal/wja ISSN Online: 2160-8822 ISSN Print: 2160-8814 Receptive Anal Intercourse and HIV Infection Gilbert R. Lavoie 1, John F. Fisher 2
More informationDENGUE AND BLOOD SAFETY. Ester C Sabino, MD, PhD Dep. of Infectious Disease/Institute of Tropical Medicine University of São Paulo
DENGUE AND BLOOD SAFETY Ester C Sabino, MD, PhD Dep. of Infectious Disease/Institute of Tropical Medicine University of São Paulo Dengue virus Arbovirus (arthropod-borne virus) virus transmitted by mosquitoes:
More informationSan Francisco Medical Monitoring Project (MMP) Maree Kay Parisi Applied Research, Community Health Epidemiology and Surveillance
San Francisco Medical Monitoring Project (MMP) Maree Kay Parisi Applied Research, Community Health Epidemiology and Surveillance Medical Monitoring Project Overview National prospective Local data and
More informationHIV transmission in the UK within Black African communities: how common is it and how do we prevent it? Dr Valerie Delpech
HIV transmission in the UK within Black African communities: how common is it and how do we prevent it? Dr Valerie Delpech We gratefully acknowledge persons living with HIV, clinicians, health advisors,
More informationTowards universal access
Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress
More informationUpdates in Infectious Diseases. Kelley Struble, DO, MS St. John Physicians Infectious Disease September 30, 2016
Updates in Infectious Diseases Kelley Struble, DO, MS St. John Physicians Infectious Disease September 30, 2016 Disclosures No financial relationships or affiliations to disclose Overview Activity Pre-Test
More informationIn the setting of measles elimination in the United States, the current measles case definition lacks specificity.
12-ID-07 Committee: Infectious Disease Title: Public Health Reporting and ational otification for Measles I. Statement of the Problem In the setting of measles elimination in the United States, the current
More informationDiagnostic Methods of HBV and HDV infections
Diagnostic Methods of HBV and HDV infections Zohreh Sharifi,ph.D Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine Hepatitis B-laboratory diagnosis Detection
More informationMI Flu Focus. Influenza Surveillance Updates Bureaus of Epidemiology and Laboratories
MI Flu Focus Influenza Surveillance Updates Bureaus of Epidemiology and Laboratories Editor: Susan Peters, DVM PetersS1@michigan.gov January 3, 2013 Surveillance and Infectious Disease Epidemiology Vol.
More informationHepatitis C Cure The Invisible Epidemic
Hepatitis C Cure The Invisible Epidemic Iris House 8 Th Annual Face of AIDS Summit Hadiyah Charles Hepatitis Advocacy Manager Harm Reduction Coalition Hepatitis C Basics A virus that can cause chronic
More informationTB/HIV/STD Epidemiology and Surveillance Branch. First Annual Report, Dated 12/31/2009
TB/HIV/STD Epidemiology and Surveillance Branch First Annual Report, Dated 12/31/29 This Enhanced Perinatal Surveillance Report is the first annual report generated by the Texas Department of State Health
More informationGOVX-B11: A Clade B HIV Vaccine for the Developed World
GeoVax Labs, Inc. 19 Lake Park Drive Suite 3 Atlanta, GA 3 (678) 384-72 GOVX-B11: A Clade B HIV Vaccine for the Developed World Executive summary: GOVX-B11 is a Clade B HIV vaccine targeted for use in
More informationManitoba Health Statistical Update on HIV/AIDS
Manitoba Health Statistical Update on HIV/AIDS 1985 - Dec 2001 Communicable Disease Control Unit Public Health Branch MANITOBA HEALTH STATISTICAL UPDATE ON HIV/AIDS 1985 TO DECEMBER 2001 HIV January 1,
More information2009 (Pandemic) H1N1 Influenza Virus
2009 (Pandemic) H1N1 Influenza Virus September 15, 2009 Olympia, Washington Anthony A Marfin Washington State Department of Health Goals Understand current situation & pattern of transmission of 2009 H1N1
More informationChronic shedders as reservoir for nosocomial. transmission of norovirus
JCM Accepts, published online ahead of print on 1 September 2010 J. Clin. Microbiol. doi:10.1128/jcm.01308-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationAcute respiratory illness This is a disease that typically affects the airways in the nose and throat (the upper respiratory tract).
Influenza glossary Adapted from the Centers for Disease Control and Prevention, US https://www.cdc.gov/flu/glossary/index.htm and the World Health Organization http://www.wpro.who.int/emerging_diseases/glossary_rev_sept28.pdf?ua=1
More information